Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
452 JPY | -1.74% | -3.42% | -21.80% |
May. 09 | StemRIM to Seek Shareholders' Approval on Capital Stock Reduction | MT |
Mar. 13 | StemRIM Announces Initiation of Phase 2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.80% | 181M | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+63.62% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-12.64% | 11.5B | |
-42.60% | 11.6B | |
+5.32% | 8.82B |
- Stock Market
- Equities
- 4599 Stock
- News StemRIM
- StemRIM Discloses Issuance Details of Stock Options to Directors